The rising popularity in GLP-1 agonists for diabetes has led to a debate about formats: transdermal systems versus capsules. Traditionally , GLP-1 therapies were only available in oral form, but the https://dawudivoy747862.myparisblog.com/41488659/glp-1-skin-applications-vs-tablets-what-suitable-for-the-patient